- Title
- Cystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non―ST-Elevation Acute Coronary Syndromes: Results from the Platelet Inhibition and Patient Outcomes Study
- Creators
- Axel Akerblom - Uppsala UniversityLars Wallentin - Uppsala UniversityPhilippe Gabriel Steg - NSERM U-698, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris, FranceRobert F Storey - University of SheffieldNils Asenblad - Uppsala UniversityStefan K James - Uppsala UniversityAgneta Siegbahn - Uppsala UniversityRichard C Becker - Duke Clinical Research Institute, Durham, NC, United StatesAndrzej Budaj - Grochowski HospitalKristen Buck - AstraZeneca Research and Development, Wilmington, DE, United StatesEvangelos Giannitsis - Medizinische Klinik, Universitätsklinikum Heidelberg, GermanyJay Horrow - AstraZenecaSteen Husted - Department of Cardiology, Århus University Hospital, Arhus, DenmarkHugo A Katus - Medizinische Klinik, Universitätsklinikum Heidelberg, Germany
- Publication Details
- Clinical chemistry (Baltimore, Md.), Vol.58(1), pp.190-199
- Publisher
- American Association for Clinical Chemistry
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Anesthesiology and Perioperative Medicine
- Identifiers
- 991020785623004721
Journal article
Cystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non―ST-Elevation Acute Coronary Syndromes: Results from the Platelet Inhibition and Patient Outcomes Study: Impact of Biomarkers, Proteomics, and Genomics in Cardiovascular Disease
Clinical chemistry (Baltimore, Md.), Vol.58(1), pp.190-199
2012
Abstract
Metrics
1 Record Views